Deferoxamine promotes osteoblastic differentiation in human periodontal ligament cells via the nuclear factor erythroid 2-related factor-mediated antioxidant signaling pathway

Journal of Periodontal Research

Volumn 49, Issue 5, 2014, Pages 563-573

  Chung, J H ^a   Kim, Y S ^a   Noh, K ^a   Lee, Y M ^a   Chang, S W ^a   Kim, E C ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Antioxidant; Deferoxamine; Iron chelator; Nuclear factor erythroid 2 related factor; Osteoblastic differentiation; Periodontal ligament cells

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; BUTHIONINE SULFOXIMINE; CALCIUM; DEFEROXAMINE; ENZYME INHIBITOR; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MALEIC ACID DERIVATIVE; MALEIC ACID DIETHYL ESTER; NFE2L2 PROTEIN, HUMAN; REACTIVE OXYGEN METABOLITE; SCAVENGER; SIDEROPHORE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR NRF2;

ANTAGONISTS AND INHIBITORS; ANTIOXIDANT RESPONSIVE ELEMENT; BONE MINERALIZATION; CELL DIFFERENTIATION; CELL LINE; CYTOLOGY; DOSE RESPONSE; DRUG EFFECTS; GENETICS; HUMAN; OSTEOBLAST; PERIODONTAL LIGAMENT; SIGNAL TRANSDUCTION;

ACETYLCYSTEINE; ANTIOXIDANT RESPONSE ELEMENTS; BUTHIONINE SULFOXIMINE; CALCIFICATION, PHYSIOLOGIC; CALCIUM; CELL DIFFERENTIATION; CELL LINE; DEFEROXAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FREE RADICAL SCAVENGERS; GLUTAMATE-CYSTEINE LIGASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; HUMANS; MALEATES; MAP KINASE SIGNALING SYSTEM; NF-E2-RELATED FACTOR 2; NF-KAPPA B; OSTEOBLASTS; PERIODONTAL LIGAMENT; REACTIVE OXYGEN SPECIES; RNA, SMALL INTERFERING; SIDEROPHORES; SIGNAL TRANSDUCTION; VITAMIN E;

EID: 84908566334     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/jre.12136     Document Type: Article

References (65)

1. Shimono M, Ishikawa T, Ishikawa H et al. Regulatory mechanisms of periodontal regeneration. Microsc Res Tech 2003;60:491-502.
2. Shiga M, Kapila YL, Zhang Q, Hayami T, Kapila S. Ascorbic acid induces collagenase-1 in human periodontal ligament cells but not in MC3T3-E1 osteoblast-like cells: potential association between collagenase expression and changes in alkaline phosphatase phenotype. J Bone Miner Res 2003;18:67-77.
3. Somerman MJ, Young MF, Foster RA, Moehring JM, Imm G, Sauk JJ. Characteristics of human periodontal ligament cells in vitro. Arch Oral Biol 1989;35:241-247.
4. Kobayashi M, Takiguchi T, Suzuki R et al. Recombinant human bone morphogenetic protein-2 stimulates osteoblast differentiation in cells isolated from human periodontal ligament. J Dent Res 1999;78:1624-1633.
5. Ishikawa S, Iwasaki K, Komaki M, Ishikawa I. Role of ascorbic acid in periodontal ligament cell differentiation. J Periodontol 2004;75:709-716.
6. Liang L, Yu JF, Wang Y, Wang G, Ding Y. Effect of estrogen receptor beta on the osteoblastic differentiation function of human periodontal ligament cells. Arch Oral Biol 2008;53:553-557.
7. Iwasaki K, Komaki M, Mimori K, Leon E, Izumi Y, Ishikawa I. IL-6 induces osteoblastic differentiation of periodontal ligament cells. J Dent Res 2008;87: 937-942.
8. Kitagawa M, Kudo Y, Iizuka S et al. Effect of F-spondin on cementoblastic differentiation of human periodontal ligament cells. Biochem Biophys Res Commun 2006;349:1050-1056.
9. Lee SK, Choi HI, Yang YS et al. Nitric oxide modulates osteoblastic differentiation with heme oxygenase-1 via the mitogen activated protein kinase and nuclear factor-kappa B pathways in human periodontal ligament cells. Bio pharm Bull 2009;32:1328-1334.
10. Kook YA, Lee SK, Son DH et al. Effects of substance P on osteoblastic differentiation and heme oxygenase-1 in human periodontal ligament cells. Cell Biol Int 2009;33:424-428.
11. Lee YM, Shin SI, Shin KS, Lee YR, Park BH, Kim EC. The role of sirtuin 1 in osteoblastic differentiation in human periodontal ligament cells. J Periodontal Res 2011;46:712-721.
12. Hentze MW, Muckenthaler MU, Andrews NC. Balancing acts: molecular control of mammalian iron metabolism. Cell 2004;117:285-297.
13. Kenner GH, Brik AB, Liu G et al. Variation of long-lived free radicals responsible for the EPR native signal in bone of aged or diseased human females and ovariectomized adult rats. Radiat Meas 2005;39:255-262.
14. Liu G, Men P, Kenner GH, Miller SC. Age-associated iron accumulation in bone: implications for postmenopausal osteoporosis and a new target for prevention and treatment by chelation. Biometals 2006;19:245-251.
15. Davis BA, Porter JB. Long-term outcome of continuous 24-hour deferoxamine infusion via indwelling intra-venous catheters in high-risk beta-thalassemia. Blood 2000;95:1229-1236.
16. Shen X, Wan C, Ramaswamy G et al. Prolyl hydroxylase inhibitors increase neoangiogenesis and callus formation following femur fracture in mice. J Orthop Res 2009;27:1298-1305.
17. Wan C, Gilbert S, Wang Y, Cao X, Shen X. Role of hypoxia inducible factor-1·pathway in bone regeneration. J Musculoskelet Neuronal Interact 2008;8:323-324.
18. Farberg AS, Jing XL, Monson LA et al. Deferoxamine reverses radiation induced hypovascularity during bone regeneration and repair in the murine mandible. Bone 2012;50:1184-1187.
19. Olivieri NF, Brittenham GM. Iron-chelating therapy and the treatment of thalassemia. Blood 1997;89:739-761.
20. Naves Díaz ML, Elorriaga R, Canteros A, Cannata Andía JB. Effect of desferrioxamine and deferiprone (L1) on the proliferation of MG-63 bone cells and on phosphatase alkaline activity. Nephrol Dial Transplant 1998; 13(suppl 3): 23-28.
21. Messer JG, Cooney PT, Kipp DE. Iron chelator deferoxamine alters iron-regulatory genes and proteins and suppresses osteoblast phenotype in fetal rat calvaria cells. Bone 2010;46:1408-1415.
22. Qu ZH, Zhang XL, Tang TT, Dai KR. Promotion of osteogenesis through b-catenin signaling by desferrioxamine. Biochem Biophys Res Commun 2008;370:332-337.
23. Kobayashi M, Yamamoto M. Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation. Antioxid Redox Signal 2005;7:385-394.
24. Ambrosio G, Zweier JL, Jacobus WE, Weisfeldt ML, Flaherty JT. Improvement of postischemic myocardial function and metabolism induced by administration of deferoxamine at the time of reflow: the role of iron in the pathogenesis of reperfusion injury. Circulation 1987;76:906-915.
25. Sauer H, Wartenberg M, Hescheler J. Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell Physiol Biochem 2001;11:173-186.
26. Philipp S, Cui L, Ludolph B et al. Desferoxamine and ethyl-3, 4-dihydroxybenzoate protect myocardium by activating NOS and generating mitochondrial ROS. Am J Physiol Heart Circ Physiol 2006;290:H450-H457.
27. Im CN, Lee JS, Zheng Y, Seo JS. Iron chelation study in a normal human hepatocyte cell line suggests that tumor necrosis factor receptor-associated protein 1 (TRAP1) regulates production of reactive oxygen species. J Cell Biochem 2007;100:474-486.
28. Seo GS, Lee SH, Choi SC et al. Iron chelator induces THP-1 cell differentiation potentially by modulating intracellular glutathione levels. Free Radic Biol Med 2006;40:1502-1512.
29. Hsieh CH, Jeng SF, Hsieh MW et al. Statin-induced heme oxygenase-1 increases NF-kappaB activation and oxygen radical production in cultured neuronal cells exposed to lipopolysaccharide. Toxicol Sci 2008;102:150-159.
30. Fujii S, Maeda H, Wada N, Kano Y, Akamine A. Establishing and characterizing human periodontal ligament fibroblasts immortalized by SV40T-antigen and hTERT gene transfer. Cell Tissue Res 2002;324:117-125.
31. Seo BM, Miura M, Gronthos S et al. Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet 2004;364:149-155.
32. Sastry SK, Horwitz AF. Adhesion-growth factor interactions during differentiation: an integrated biological response. Dev Biol 1996;180:455-467.
33. Ivanovski S, Gronthos S, Shi S, Bartold PM. Stem cells in the periodontal ligament. Oral Dis 2006;12:358-363.
34. Campisi J. Cellular senescence as a tumor-suppressor mechanism. Trend Cell Biol 2001;11(suppl 1):27-31.
35. Hayami T, Zhang Q, Kapila Y, Kapila S. Dexamethasone's enhancement of osteoblastic markers in human periodontal ligament cells is associated with inhibition of collagenase expression. Bone 2007;40:93-104.
36. Cormier C. Markers of bone metabolism. Curr Opin Rheumatol 1995;7:243-248.
37. Gonzalez Suarez I, Fernandez Martin JL, Naves Diaz M, Cannata Andia JB. Effect of desferrioxamine and deferiprone on osteocalcin secretion in osteoblast-type cells. Nefrologia 2003;23(suppl 2): 27-31.
38. Kaspar JW, Niture SK, Jaiswal AK. Nrf2:INrf2 (Keap1) signaling in oxidative stress. Free Radic Biol Med 2009;47:1304-1309.
39. Langen R, Schols A, Kelders M, Van der Velden J, Wouters E, Janssen-Heininger YM. Tumor necrosis factor-inhibits myogenesis through redox-dependent and-independent pathways. Am J Physiol 2002;283:C714-C721.
40. Ardite E, Barbera JA, Roca J, Fernández-Checa JC. Glutathione depletion impairs myogenic differentiation of murine skeletal muscle C2C12 cells through sustained NF-kappaB activation. Am J Pathol 2004;165:719-728.
41. Drowley L, Okada M, Beckman S et al. Cellular antioxidant levels influence muscle stem cell therapy. Mol Ther 2010;18:1865-1873.
42. Allameh A, Esmaeli S, Kazemnejad S, Soleimani M. Differential expression of glutathione S-transferases P1-1 and A1-1 at protein and mRNA levels in hepatocytes derived from human bone marrow mesenchymal stem cells. Toxicol In Vitro 2009;23:674-679.
43. Rodríguez-Martín E, Casarejos MJ, Bazán E, Canals S, Herranz AS, Mena MA. Nitric oxide induces differentiation in the NB69 human catecholamine-rich cell line. Neuropharmacology 2000;39:2090-2100.
44. Romagnoli C, Marcucci G, Favilli F et al. Role of GSH/GSSG redox couple in osteogenic activity and osteoclastogenic markers of human osteoblast-like SaOS-2 cells. FEBS J 2013;280:867-879.
45. Piao YJ, Seo YH, Hong F et al. Nox 2 stimulates muscle differentiation via NF-kappaB/iNOS pathway. Free Radic Biol Med 2005;38:989-1001.
46. Wang N, Xie K, Huo S, Zhao J, Zhang S, Miao J. Suppressing phosphatidylcholine-specific phospholipase C and elevating ROS level, NADPH oxidase activity and Rb level induced neuronal differentiation in mesenchymal stem cells. J Cell Biochem 2007;100:1548-1557.
47. Bekhite MM, Finkensieper A, Abou-Zaid FA et al. Static electromagnetic fields induce vasculogenesis and chondro-osteogenesis of mouse embryonic stem cells by reactive oxygen species-mediated up-regulation of vascular endothelial growth factor. Stem Cells Dev 2010;19: 731-743.
48. Tormos KV, Anso E, Hamanaka RB et al. Mitochondrial complex III ROS regulate adipocyte differentiation. Cell Metab 2011;14:537-544.
49. Meister A. Glutathione deficiency produced by inhibition of its synthesis, and its reversal; applications in research and therapy. Pharmacol Ther 1991;51: 155-194.
50. Aruoma OI, Halliwell B, Hoey BM, Bulter J. The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, an hypochlorous acid. Free Radic Biol Med 1989;6:593-597.
51. Factor VM, Laskowska D, Jensen MR, Woitach JT, Popescu NC, Thorgeirsson SS. Vitamin E reduces chromosomal damage and inhibits hepatic tumor formation in a transgenic mouse model. Proc Natl Acad Sci USA 2001;97: 2196-2201.
52. Esposito F, Agosti V, Morrone G et al. Inhibition of the differentiation of human myeloid cell lines by redox changes induced through glutathione depletion. Biochem J 1994;301:649-653.
53. Lee HJ, Pi SH, Kim Y et al. Effects of nicotine on antioxidant defense enzymes and RANKL expression in human periodontal ligament cells. J Periodontol 2009;80:1281-1288.
54. Min KS, Lee HJ, Kim HO et al. Hydrogen peroxide induces heme oxygenase-1 and dentin sialophosphoprotein mRNA in human pulp cells. J Endod 2008;34:983-989.
55. Jun JH, Lee SH, Kwak HB et al. N-acetylcysteine stimulate osteoblastic differentiation of mouse calvarial cells. J Cell Biochem 2008;103:1246-1255.
56. Markel TA, Crisostomo PR, Wang M et al. Iron chelation acutely stimulates fetal human intestinal cell production of IL-6 and VEGF while decreasing HGF: the roles of p38, ERK, and JNK MAPK signaling. Am J Physiol Gastrointest Liver Physiol 2007;292:G958-G963.
57. Lee SK, Lee J, Min SK et al. Iron chelator differentially activates macrophage inflammatory protein-3alpha/CCL20 in immortalized and malignant human oral keratinocytes. Arch Oral Biol 2008;53: 801-809.
58. Lee HJ, Lee J, Lee SK, Lee SK, Kim EC. Differential regulation of iron chelator-induced IL-8 synthesis via MAP kinase and NF-kappaB in immortalized and malignant oral keratinocytes. BMC Cancer 2007;7:176.
59. Kim DY, Jun JH, Lee HL et al. N-acetyicysteine prevents lps-lnduced pro-inflammatory cytokines and mmp2 production in gingival fibroblasts. Arch Pharm Res 2007;30:1283-1292.
60. An JM, Kim SS, Rhie JH, Shin DM, Seo SR, Seo JT. Carmustine induces ERK- and JNK-dependent cell death of neuronally-differentiated PC12 cells via generation of reactive oxygen species. Toxicol In Vitro 2011;25:1359-1365.
61. Barchowsky A, Dudek EJ, Treadwell MD, Wetterhahn KE. Arsenic induces oxidant stress and NF-KB activation in cultured aortic endothelial cells. Free Radic Biol Med 1996;21:783-790.
62. Liu YC, Hsieh CW, Wu CC, Wung BS. Chalcone inhibits the activation of NF-kappaB and STAT3 in endothelial cells via endogenous electrophile. Life Sci 2007;80:1420-1430.
63. Haddad JJ, Land SC. Redox signaling-mediated regulation of lipopolysaccharide-induced proinflammatory cytokine biosynthesis in alveolar epithelial cells. Antioxid Redox Signal 2002;4:179-193.
64. Zhang W, Li G, Deng R, Deng L, Qiu S. New bone formation in a true bone ceramic scaffold loaded with desferrioxamine in the treatment of segmental bone defect: a preliminary study. J Orthop Sci 2012;17:289-298.
65. 2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 1998;95:7987-7992.